Lyell Immunopharma, Inc. (LYEL)
NASDAQ·Healthcare·Biotechnology
$12.73
+2.34%
Mkt Cap $279.31M
Analyst Ratings
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$46.00
Range $44.00 – $49.00
Implied Upside
+261.3%
Consensus $46.00 vs current $12.73
NASDAQ·Healthcare·Biotechnology
$12.73
+2.34%
Mkt Cap $279.31M
Buy
2
Hold
0
Sell
0
Price Target (7 analysts)
$46.00
Range $44.00 – $49.00
+261.3%
Consensus $46.00 vs current $12.73